Larson SM - Search Results

1

Efficacy of HER2-Targeted Intraperitoneal ²²⁵Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.

Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B, Patel M, Xu H, Guo HF, Zanzonico PB, Monette S, Yang G, Ouerfelli O, Nash GM, Cercek A, Fung EK, Howell RW, Larson SM, Cheal SM, Cheung NV. Chung SK, et al. Among authors: larson sm. J Nucl Med. 2023 Sep;64(9):1439-1445. doi: 10.2967/jnumed.122.265095. Epub 2023 Jun 22. J Nucl Med. 2023. PMID: 37348919 Free PMC article.

2

PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma.

Larson SM, Pentlow KS, Volkow ND, Wolf AP, Finn RD, Lambrecht RM, Graham MC, Di Resta G, Bendriem B, Daghighian F, et al. Larson SM, et al. J Nucl Med. 1992 Nov;33(11):2020-3. J Nucl Med. 1992. PMID: 1432165 Free article.

3

In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected].

Mehta BM, Rosa E, Fissekis JD, Bading JR, Biedler JL, Larson SM. Mehta BM, et al. Among authors: larson sm. J Nucl Med. 1992 Jul;33(7):1373-7. J Nucl Med. 1992. PMID: 1613580 Free article.

4

Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.

Larson SM, Carrasquillo JA, Colcher DC, Yokoyama K, Reynolds JC, Bacharach SA, Raubitchek A, Pace L, Finn RD, Rotman M, et al. Larson SM, et al. J Nucl Med. 1991 Sep;32(9):1661-7. J Nucl Med. 1991. PMID: 1880565 Free article.

5

Three-dimensional dosimetry for radioimmunotherapy treatment planning.

Sgouros G, Chiu S, Pentlow KS, Brewster LJ, Kalaigian H, Baldwin B, Daghighian F, Graham MC, Larson SM, Mohan R. Sgouros G, et al. Among authors: larson sm. J Nucl Med. 1993 Sep;34(9):1595-601. J Nucl Med. 1993. PMID: 8394886 Free article.

6

Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.

Daghighian F, Barendswaard E, Welt S, Humm J, Scott A, Willingham MC, McGuffie E, Old LJ, Larson SM. Daghighian F, et al. Among authors: larson sm. J Nucl Med. 1996 Jun;37(6):1052-7. J Nucl Med. 1996. PMID: 8683300 Free article.

7

Bone marrow dosimetry: regional variability of marrow-localizing antibody.

Sgouros G, Jureidini IM, Scott AM, Graham MC, Larson SM, Scheinberg DA. Sgouros G, et al. Among authors: larson sm. J Nucl Med. 1996 Apr;37(4):695-8. J Nucl Med. 1996. PMID: 8691269 Free article. Clinical Trial.

8

Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial.

Grant SC, Kostakoglu L, Kris MG, Yeh SD, Larson SM, Finn RD, Oettgen HF, Cheung NV. Grant SC, et al. Among authors: larson sm. Eur J Nucl Med. 1996 Feb;23(2):145-9. doi: 10.1007/BF01731837. Eur J Nucl Med. 1996. PMID: 8925848 Clinical Trial.

9

Implementation and evaluation of patient-specific three-dimensional internal dosimetry.

Kolbert KS, Sgouros G, Scott AM, Bronstein JE, Malane RA, Zhang J, Kalaigian H, McNamara S, Schwartz L, Larson SM. Kolbert KS, et al. Among authors: larson sm. J Nucl Med. 1997 Feb;38(2):301-8. J Nucl Med. 1997. PMID: 9025759 Free article.

10

Current status of radioimmunotherapy.

Larson SM, Divgi CR, Scott A, Sgouros G, Graham MC, Kostakoglu L, Scheinberg D, Cheung NK, Schlom J, Finn RD. Larson SM, et al. Nucl Med Biol. 1994 Jul;21(5):785-92. doi: 10.1016/0969-8051(94)90050-7. Nucl Med Biol. 1994. PMID: 9241655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

682 results

Search Page